Innovation Pharmaceuticals Inc.
IPIX · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | -$0 | $0 | $0 |
| % Growth | 100% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | – | 1,650% | – | – |
| R&D Expenses | $0 | $0 | $0 | -$0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $0 |
| Operating Income | -$1 | -$1 | -$1 | -$0 |
| % Margin | – | 11,200% | – | – |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$1 | -$1 | -$1 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$1 | -$1 | -$0 |
| % Margin | – | 11,350% | – | – |
| EPS | -0.002 | -0.001 | -0.002 | -0.001 |
| % Growth | -30.8% | 13.3% | -114.3% | – |
| EPS Diluted | -0.002 | -0.001 | -0.002 | -0.001 |
| Weighted Avg Shares Out | 518 | 518 | 497 | 504 |
| Weighted Avg Shares Out Dil | 518 | 518 | 497 | 504 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$1 | -$1 | -$0 |
| % Margin | – | 9,650% | – | – |